Howard Raff PhD
Howard Raff, PhD, is Aimmune’s Chief Operating Officer. Previously, Dr. Raff was COO at APT Pharmaceuticals and Head of West Coast Operations for The Biologics Consulting Group. He also held executive positions at Chiron Corporation, including Vice President, Development Management, which entailed responsibility for development of the biopharmaceutical portfolio. Dr. Raff spent 11 years in discovery, research and development for Genetic Systems and Bristol-Myers Squibb.
He has had significant involvement with more than 50 investigational projects, of which several have become marketed pharmaceutical products in the United States and Europe. Early in his career, Dr. Raff was an adjunct associate professor at the University of Washington Medical School. He also served a post-doctoral fellowship for the Howard Hughes Medical Institute at the University of California, San Francisco. Dr. Raff obtained MS and PhD degrees in Immunology and Microbiology from Washington State University.